Start Date
September 30, 2017
Primary Completion Date
January 31, 2018
Study Completion Date
January 31, 2018
GRT7014 - Abuse Deterrend Tablet
Single oral dose in one of the four cross-over trial periods and in the standard cross-over trial periods.
Norco 5Mg-325Mg Tablet
Single oral dose in one of the four cross-over trial periods and in the standard cross-over trial periods.
US001: PRA Health Sciences, Lenexa
Lead Sponsor
Grünenthal GmbH
INDUSTRY